BioJapan
Representatives from Venture Valuation and Biotechgate
will participate in BioJapan
Below you find a list of upcoming events in the Life Sciences industry. We will be attending all events which are flagged with the Biotechgate / Venture Valuation logo. If you are participating and want to learn more, please schedule a meeting.
Representatives from Venture Valuation and Biotechgate
will participate in BioJapan
AusBiotech Invest is a core pillar of Australia’s Biggest Week in Biotech, a curated capital convening designed to strengthen the investment and capital environment around Australian life sciences. More than a company showcase or investor-matching exercise, this AusBiotech Invest event will on the Gold Coast will bring together active investors, capital partners and a specially selected high potential companies to explore investment opportunities, market insights, syndication pathways and the broader conditions required to fund and scale high-potential Australian innovation. The program is being shaped through ongoing engagement with investors and capital partners to ensure it delivers meaningful opportunities for discussion, connection and investment consideration.
Representatives from Venture Valuation and Biotechgate
will participate in AusBiotech Invest
The AusBiotech International Conference is Australia’s largest biotechnology conference and part of Australia’s Biggest Week in Biotech, connecting local expertise with Australian and international partners to accelerate innovation and impact. Join us at the Gold Coast Convention & Exhibition Centre, Queensland, from 21 to 23 October, 2026. This October, AusBiotech International Conference will be presented alongside the AusMedtech Conference, connecting local expertise with Australian and international partners to accelerate innovation and impact. Your International Conference registration will include access to all AusMedtech events.
Representatives from Venture Valuation and Biotechgate
will participate in AusBiotech International Conference
BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
Demy-Colton
Representatives from Venture Valuation and Biotechgate
will participate in BioFuture 2026
Through expert-led discussions and networking, attendees will gain insights into the impact of AI and emerging technologies, access to early-stage capital, regulatory developments, and the strategies and partnerships needed to accelerate the path from discovery to patient impact.
Bringing together the healthcare ecosystems of France, Germany, and Switzerland, the Health Innovation Nexus is the leading trinational event for innovation and collaboration in the Upper Rhine region. It connects companies, hospitals, universities, research organizations, public authorities, and innovation stakeholders to exchange ideas, spark partnerships, and shape the future of healthcare. Discussions will focus on emerging technologies, health data, European health policy, resilience, supply chains, and cross-border cooperation. A dedicated B2B matchmaking platform will enable participants to build valuable connections and launch new collaborative projects across borders.
Representatives from Venture Valuation and Biotechgate
will participate in Health Innovation Nexus
BIO-Europe is Europe’s largest and longest-running partnering conference for the global biotechnology and biopharma industry. The event brings together 5800+ participants from more than 3,200 companies across 60+ countries, to build partnerships, share insights, and explore business opportunities in life sciences.
Informa
Representatives from Venture Valuation and Biotechgate
will participate in BIO-Europe® 2026
LSX Investival Showcase London brings together biotech innovators, medtech pioneers, healthcare investors and corporate strategics from across Europe and beyond, creating a dynamic environment for investment discussions, partnering opportunities and business development. For life science companies, the Investival Showcase offers a valuable opportunity to build visibility with the European and global market, pitch to active investors and build new connections through organised partnering and networking opportunities. Taking place on the first day of London Life Science Week, it's growing in size and scale. It's the first and biggest public event of the week, open to the wider life science community, and offers full partnering facilities to all attendees. Get a 15% discount to LSX Investival Showcase Europe by using the promo code: VENTUREVALUATION15.
Informa
Representatives from Venture Valuation and Biotechgate
will participate in LSX Investival Showcase London
BioPharma Deals Conference 2026 is a focused gathering for the biopharma dealmaking community, bringing together senior professionals from biotech and pharmaceutical companies, investors, advisors, and other key industry stakeholders to explore opportunities across business development, licensing, strategic partnerships, investment, M&A, and co-development. The event will feature: High-level networking with senior industry professionals Curated one-to-one partnering meetings Discussions on business development, licensing, investment, and strategic transactions Opportunities to connect with biotech innovators, pharma leaders, investors, and advisors A focused platform for developing meaningful business and dealmaking connections
Online
Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.
Biotechgate
Representatives from Venture Valuation and Biotechgate
will participate in Biotechgate Digital Partnering December 2026
The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives.
Representatives from Venture Valuation and Biotechgate
will participate in Biotech Showcase™
The RESI Conference will be held on January 11-12 at the San Francisco Marriott Marquis, featuring two days in-person event followed by three days (January 13, 18 & 19) of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 600 early-stage life science investors, innovators, and industry experts. This RESI is held concurrently with JP Morgan Healthcare Week. As the largest and most comprehensive healthcare investment symposium, it attracts thousands of life science professionals globally.
Get $300 off registration by using the code: BTG
Life Science Nation
Representatives from Venture Valuation and Biotechgate
will participate in RESI JPM 2027
Set in one of Europe's leading life sciences hubs, the Basel conference explores how drug discovery can scale through advanced technologies, European investment, strategic partnerships, and cross-border collaboration.
BIO-Europe Spring is Europe's largest springtime biotech partnering event, bringing together over 3,700 leaders and innovators in the life sciences industry. It's designed for partnering, business development, and licensing opportunities in biotechnology and pharmaceuticals.
Informa
Representatives from Venture Valuation and Biotechgate
will participate in BIO-Europe Spring® 2027
Redefining Early Stage Investments
Created in partnership with the Kobe Biomedical Innovation Cluster (KBIC), RESI Asia Japan is the gateway connecting early-stage life science companies with Japan’s leading pharmaceutical giants and global capital. Following RESI Boston and RESI JPM, this premiere event completes a 7-month global partnering cycle, offering fundraising startups unparalleled access to licensing deals, cross-border investment syndicates, and Asia’s largest life science market.
Life Science Nation
Representatives from Venture Valuation and Biotechgate
will participate in RESI Asia Japan 2027
The Swiss Biotech Day conference celebrates the power of international collaboration, driving innovation, partnerships and global impact. Since 2021, the Swiss Biotech Day has grown by an average of 35% every year, establishing itself as one of the world’s premier biotechnology conferences. It brings together life sciences leaders from across the globe to spark collaboration, innovation and meaningful partnerships. In 2026, the event welcomed more than 3,500 participants from 58 countries, including 31 international delegations, a testament to its global reach and impact. It was by far the biggest and most international edition of the Swiss Biotech Day ever. Join the Swiss Biotech Day to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing. In addition, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments, public-private partnerships, R&D collaborations and the exchange of best practices.
Representatives from Venture Valuation and Biotechgate
will participate in Swiss Biotech Day 2027
The ChinaBio® Partnering Forum is a leading event for cross-border partnering, giving the global biopharma community the chance to expand its presence in China's life-sciences market through unrivalled cross-border partnering. Engage with the largest network of potential partners to accelerate cross-border strategies and grow your presence in the Chinese market.
Informa
Representatives from Venture Valuation and Biotechgate
will participate in ChinaBio™ Partnering Forum 2027
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from around the world.
BIO
Representatives from Venture Valuation and Biotechgate
will participate in BIO International Convention